phenytoin and mexiletine

phenytoin has been researched along with mexiletine in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	30 (63.83)	18.7374
1990's	3 (6.38)	18.2507
2000's	6 (12.77)	29.6817
2010's	8 (17.02)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Anger, T; Madge, DJ; Mulla, M; Riddall, D	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Campillo, NE; Guerra, A; Páez, JA	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Sen, S; Sinha, N	1
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Budziszewska, B; Koczurkiewicz, P; Marona, H; Pańczyk, K; Pękala, E; Piska, K; Pytka, K; Rapacz, A; Starek-Świechowicz, B; Waszkielewicz, AM	1
Julian, DG	1
Theisen, K	1
Carson, IW; Lyons, SM; Shanks, RG	1
Koch-Weser, J	1
Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA	1
Kwieciński, H; Ostrzycki, A; Ryniewicz, B	1
Chiavarelli, M; Chiavarelli, R; del Basso, P; Fabi, F; Stati, T	1
Podrid, PJ	1
Sanchez-Chapula, J; Valenzuela, C	1
Yamaguchi, I	1
Somberg, J	1
Roden, DM; Siddoway, LA; Woosley, RL	1
Andersson, KE; Wettrell, G	1
Huang, SK; Marcus, FI	1
Di Biase, M; Favale, S; Rizzon, P; Visani, L	1
Garson, A; Moak, JP; Smith, RT	1
Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D	1
Fossati, C; Giustiniani, S	1
Jahrmärker, H; Theisen, K	1
Courtney, KR	1
Rosen, MR; Wit, AL	1
Block, PJ; Winkle, RA	1
Markut, H; Reisecker, F; Tulzer, W	1
Gülzow, J; Hildenbrand, H; Hönerloh, HJ; Lenarz, T	1
Burckhardt, D; Follath, F; Hoffmann, A; Schütz, E; White, R	1
Cho, YW; Kuemmerle, HP; Singh, BN	1
Hashimoto, K; Imai, S; Satoh, H; Shibuya, T	1
Chiariello, M; Condorelli, M; Ferro, G; Tari, MG; Ungaro, B; Vigorito, C	1
Carlier, J	1
Winkle, RA	1
Begg, EJ; Chinwah, PM; Day, RO; Wade, DN; Webb, C	1
Almotrefi, AA; Baker, JB	1
Fontaine, B	1
Eguchi, H; Eguchi, K; Hayashi, H; Kaibara, M; Shirabe, S; Taniyama, K; Tsujino, A	1
Ates, O; Cakir, CO; Cayli, SR; Gurses, I; Kocak, A; Tarim, O; Turkoz, Y	1
Banach, M; Borowicz-Reutt, KK; Piskorska, B	1

Reviews

18 review(s) available for phenytoin and mexiletine

Article	Year
Medicinal chemistry of neuronal voltage-gated sodium channel blockers. Journal of medicinal chemistry, 2001, Jan-18, Volume: 44, Issue:2 Topics: Amyotrophic Lateral Sclerosis; Analgesics; Anticonvulsants; Epilepsy; Humans; Ion Channel Gating; Models, Molecular; Mutation; Nerve Tissue Proteins; Neuroprotective Agents; Protein Binding; Sodium Channel Blockers; Sodium Channels; Stroke	2001
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Cardiac arrhythmias - a short review. Scottish medical journal, 1976, Volume: 21, Issue:3 Topics: Adrenergic beta-Agonists; Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electrocardiography; Humans; Lidocaine; Mexiletine; Pacemaker, Artificial; Phenytoin; Procainamide; Quinidine; Verapamil	1976
Anti-arrhythmic drugs. British journal of anaesthesia, 1979, Volume: 51, Issue:7 Topics: Adrenergic beta-Antagonists; Anesthetics; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Humans; Intraoperative Complications; Lidocaine; Mexiletine; Phenytoin; Procainamide; Succinylcholine	1979
Prevention of sudden coronary death by chronic antiarrhythmic therapy. Advances in cardiology, 1978, Volume: 25 Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation	1978
The role of antiarrhythmic drugs in prevention of sudden cardiac death. Cardiovascular clinics, 1985, Volume: 15, Issue:3 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide	1985
[The interaction of antiarrhythmic drugs with other drugs]. Kokyu to junkan. Respiration & circulation, 1985, Volume: 33, Issue:8 Topics: Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Humans; Lidocaine; Mexiletine; Phenytoin; Procainamide; Quinidine	1985
Antiarrhythmic drug therapy. Recent advances and current status. Cardiology, 1985, Volume: 72, Issue:5-6 Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil	1985
Clinical pharmacology of old and new antiarrhythmic drugs. Cardiovascular clinics, 1985, Volume: 15, Issue:3 Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide	1985
Cardiovascular drugs. I: Antidysrhythmic drugs. Therapeutic drug monitoring, 1986, Volume: 8, Issue:1 Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil	1986
Antiarrhythmic drug therapy of ventricular arrhythmias. Current problems in cardiology, 1986, Volume: 11, Issue:4 Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil	1986
Class 1B agents lidocaine, mexiletine, tocainide, phenytoin. European heart journal, 1987, Volume: 8 Suppl A Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; Phenytoin; Tocainide	1987
Antiarrhythmic drug therapy for sustained ventricular tachycardia. Heart & lung : the journal of critical care, 1984, Volume: 13, Issue:6 Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide	1984
[Therapy of cardiac arrhythmias]. La Clinica terapeutica, 1984, Sep-30, Volume: 110, Issue:6 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Digitalis Glycosides; Electric Countershock; Electroconvulsive Therapy; Humans; Lidocaine; Mexiletine; Phenytoin	1984
[Medical treatment of extrasystole and tachycardia (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1980, Jan-18, Volume: 122, Issue:3 Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil	1980
Electropharmacology of antiarrhythmic drugs. American heart journal, 1983, Volume: 106, Issue:4 Pt 2 Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil	1983
Hemodynamic effects of antiarrhythmic drugs. The American journal of cardiology, 1983, Sep-22, Volume: 52, Issue:6 Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide	1983
[Ion-channel related muscular diseases]. La Revue de medecine interne, 1999, Volume: 20, Issue:9 Topics: Acetazolamide; Anti-Arrhythmia Agents; Anticonvulsants; Carbamazepine; Humans; Hypokalemic Periodic Paralysis; Ion Channels; Mexiletine; Mutation; Myotonia; Paralysis, Hyperkalemic Periodic; Phenytoin; Potassium Chloride	1999

Trials

3 trial(s) available for phenytoin and mexiletine

Article	Year
Prevention of sudden coronary death by chronic antiarrhythmic therapy. Advances in cardiology, 1978, Volume: 25 Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Disopyramide; Drug Evaluation; Humans; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Time Factors; Ventricular Fibrillation	1978
Treatment of myotonia with antiarrhythmic drugs. Acta neurologica Scandinavica, 1992, Volume: 86, Issue:4 Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Humans; Male; Mexiletine; Middle Aged; Myotonia; Myotonia Congenita; Myotonic Dystrophy; Neurologic Examination; Phenytoin; Prospective Studies; Single-Blind Method; Tocainide	1992
The role of antiarrhythmic drugs in prevention of sudden cardiac death. Cardiovascular clinics, 1985, Volume: 15, Issue:3 Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Disopyramide; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Random Allocation; Tocainide	1985

Other Studies

28 other study(ies) available for phenytoin and mexiletine

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model. European journal of medicinal chemistry, 2011, Volume: 46, Issue:2 Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship	2011
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovascular research, 2011, Jul-01, Volume: 91, Issue:1 Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Design, synthesis and anticonvulsant-analgesic activity of new MedChemComm, 2017, Jan-01, Volume: 8, Issue:1 Topics:	2017
[Drug therapy of tachyarrhythmias (author's transl)]. Klinische Wochenschrift, 1978, Feb-15, Volume: 56, Issue:4 Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil	1978
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses. Drugs, 1978, Volume: 15, Issue:4 Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil	1978
Vascular effects of lignocaine after coronary artery surgery. Lancet (London, England), 1990, May-05, Volume: 335, Issue:8697 Topics: Coronary Artery Bypass; Drug Evaluation; Humans; Lidocaine; Mexiletine; Muscle Contraction; Phenytoin; Saphenous Vein; Tachycardia	1990
Electrophysiologic interactions between mexiletine-quinidine and mexiletine-ropitoin in guinea pig papillary muscle. Journal of cardiovascular pharmacology, 1989, Volume: 14, Issue:5 Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Drug Interactions; Electric Stimulation; Electrophysiology; Female; Guinea Pigs; Heart; In Vitro Techniques; Kinetics; Male; Membrane Potentials; Mexiletine; Papillary Muscles; Phenytoin; Quinidine; Temperature	1989
Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease. Journal of the American College of Cardiology, 1987, Volume: 10, Issue:4 Topics: Adolescent; Adult; Arrhythmias, Cardiac; Child; Child, Preschool; Electrocardiography; Heart Defects, Congenital; Heart Ventricles; Humans; Infant; Mexiletine; Monitoring, Physiologic; Phenytoin	1987
Depressant effects of drugs used in myotonia therapy. Proceedings of the Western Pharmacology Society, 1982, Volume: 25 Topics: Animals; In Vitro Techniques; Ion Channels; Lidocaine; Mexiletine; Muscle Contraction; Myotonia; Phenytoin; Procainamide; Quinidine; Rana catesbeiana; Tocainide	1982
[The problem of diagnosis and therapy of myotonic dystrophy]. Wiener medizinische Wochenschrift (1946), 1983, Jun-30, Volume: 133, Issue:12 Topics: Adult; Biopsy; Child; Deglutition Disorders; Dysarthria; Electromyography; Female; Humans; Male; Mexiletine; Muscles; Myotonic Dystrophy; Phenytoin	1983
[Effect of membrane-effective drugs (anti-arrhythmia agents) on acoustically evoked brain-stem potentials]. Laryngologie, Rhinologie, Otologie, 1984, Volume: 63, Issue:2 Topics: Animals; Anti-Arrhythmia Agents; Audiometry; Audiometry, Evoked Response; Lidocaine; Mexiletine; Phenytoin; Procainamide; Rabbits	1984
Suppression of high-grade ventricular ectopic activity by antiarrhythmic drug treatment as a marker for survival in patients with chronic coronary artery disease. American heart journal, 1984, Volume: 107, Issue:6 Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Female; Humans; Male; Mexiletine; Middle Aged; Phenytoin; Prognosis; Quinidine; Retrospective Studies	1984
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II. International journal of clinical pharmacology, therapy, and toxicology, 1981, Volume: 19, Issue:5 Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Propranolol; Tocainide	1981
Quantitative analysis of the antiarrhythmic effect of drugs on canine ventricular arrhythmias by the determination of minimum effective plasma concentrations. Japanese circulation journal, 1983, Volume: 47, Issue:1 Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Dogs; Female; Lidocaine; Male; Mexiletine; Phenytoin; Verapamil	1983
Intropic effects of several antiarrhythmic drugs. Japanese heart journal, 1983, Volume: 24, Issue:3 Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Blood Pressure; Bunaftine; Coronary Disease; Disopyramide; Heart Rate; Hemodynamics; Humans; Lidocaine; Mexiletine; Middle Aged; Myocardial Contraction; Phenytoin; Procainamide	1983
Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics. Acta cardiologica. Supplementum, 1980, Issue:25 Topics: Ajmaline; Animals; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Dogs; Electrocardiography; Hemodynamics; Injections, Intravenous; Mexiletine; Myocardial Contraction; Phenytoin; Procainamide; Propylamines	1980
Clinical efficacy of antiarrhythmic drugs in prevention of sudden coronary death. Annals of the New York Academy of Sciences, 1982, Volume: 382 Topics: Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Dose-Response Relationship, Drug; Electrocardiography; Humans; Kinetics; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Risk	1982
Enhanced metabolism of mexiletine after phenytoin administration. British journal of clinical pharmacology, 1982, Volume: 14, Issue:2 Topics: Adult; Biological Availability; Drug Interactions; Female; Humans; Kinetics; Male; Mexiletine; Phenytoin; Propylamines	1982
Investigation of the antifibrillatory activity of some anticonvulsant gamma-aminobutyric acid-transaminase inhibitors in the rabbit isolated heart: comparison with phenytoin and mexiletine. British journal of pharmacology, 1980, Volume: 71, Issue:2 Topics: 4-Aminobutyrate Transaminase; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Electric Stimulation; Female; Heart; In Vitro Techniques; Male; Mexiletine; Myocardium; Phenytoin; Propylamines; Rabbits; Transaminases; Ventricular Fibrillation	1980
Acetazolamide acts directly on the human skeletal muscle chloride channel. Muscle & nerve, 2006, Volume: 34, Issue:3 Topics: Acetazolamide; Anti-Arrhythmia Agents; Anticonvulsants; Buffers; Cell Line; Chloride Channels; Humans; Ion Channel Gating; Kidney; Membrane Potentials; Mexiletine; Muscle, Skeletal; Patch-Clamp Techniques; Phenytoin; Protons; Transfection	2006
Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2007, Volume: 14, Issue:7 Topics: Animals; Behavior, Animal; Disease Models, Animal; Lipid Peroxidation; Locomotion; Male; Mexiletine; Motor Activity; Phenytoin; Psychomotor Performance; Rats; Rats, Wistar; Riluzole; Sodium Channel Blockers; Spinal Cord Injuries; Statistics, Nonparametric; Time Factors; Water	2007
Mexiletine and its Interactions with Classical Antiepileptic Drugs: An Isobolographic Analysis. Neurochemical research, 2016, Volume: 41, Issue:5 Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Drug Interactions; Electroshock; Male; Memory, Long-Term; Mexiletine; Mice; Motor Activity; Phenobarbital; Phenytoin; Seizures; Tissue Distribution; Valproic Acid	2016